Fund
Janus Henderson Investors
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 3
- Lead
- 1
- New entries
- 1
- Follow ons
- 1
- Latest operation
- 9 September 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 09 Sept | United States, Biotech | Series D and later | 275 M$ | Participant |
| 11 Aug | United States, Biotech | Series C | 90 M$ | Lead |
| 08 Aug | United States, Biotech | Series B | 118 M$ | Existing investor |
Co investors 23 funds crossed
- Adage Capital Management 1 operation
- ADAR1 Capital Management 1 operation
- Aisling Capital 1 operation
- ARCH Venture Partners 1 operation
- Braidwell 1 operation
- Catalio Capital Management 1 operation
- Cormorant Asset Management 1 operation
- Farallon Capital Management 1 operation
- Fidelity Management & Research 1 operation
- GV 1 operation
- Illumina Ventures 1 operation
- Invus 1 operation
- Mass General Brigham Ventures 1 operation
- Matrix Capital Management 1 operation
- Nolan Capital 1 operation
- Novo Holdings 1 operation
- Octagon Capital 1 operation
- RTW Investments 1 operation
- Samsara Biocapital 1 operation
- Sanofi Ventures 1 operation
- Sofinnova Investments 1 operation
- SoftBank Vision Fund 2 1 operation
- Venrock 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.